Negative impact of disease progression on quality of life of patients with advanced breast cancer – Data from the TMK/MaLife project. 13. Dezember 2019 Marschner N, Zacharias S, Welt A, Decker T, Nusch A, Kruggel L, Jänicke M, for the TMK Registry group, 2019. The Breast 48 (suppl2), 71. https://doi.org/10.1016/S0960-9776(19)30610-1 Application study of the EQ-5D-5L in Oncology: Linking self-reported quality of life of patients with advanced or metastatic colorectal cancer to clinical data from a german tumor registry: Results from a TOBIT regression. K Borchert C Jacob N Wetzel M Jaenicke E Eggers A Sauer N Marschner D Meise J Altevers T Mittendorf S Braun W Greiner, 2019. Weiterlesen Therapy of advanced breast cancer for patients with hormone receptor-positive / HER2-negative and HER2-positive tumors is changing real life. First results from the prospective, national research platform OPAL for patients with advanced breast cancer in Germany. E. Stickeler, N. Harbeck, M. Thill, A. Nusch, M. Chiabudini, L. Kruggel, M. Jänicke, N. Marschner, M. Zahn, A. Welt, A. Wöckel, T. Decker, OPAL… Weiterlesen